ClinVar Miner

Submissions for variant NM_004304.5(ALK):c.4596C>T (p.Asn1532=) (rs1881422)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Clinical Services Laboratory,Illumina RCV001080667 SCV000429913 benign Neuroblastoma 3 2018-01-12 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.
Invitae RCV001080667 SCV000554728 benign Neuroblastoma 3 2019-12-31 criteria provided, single submitter clinical testing
Ambry Genetics RCV000575366 SCV000672459 benign Hereditary cancer-predisposing syndrome 2018-09-28 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000590798 SCV000698299 benign not provided 2016-08-24 criteria provided, single submitter clinical testing Variant summary: The ALK c.4596C>T (p.Asn1532Asn) variant involves the alteration of a non-conserved nucleotide, resulting in a synonymous change. Mutation Taster predicts a benign outcome for this variant. 4/5 splice prediction tools predict no significant impact on normal splicing. In addition, ESE finder predicts that this variant may not affect ESE sites. This variant was found in 684/121410 control chromosomes (17 homozygotes), predominantly observed in the African subpopulation at a frequency of 0.0620796 (646/10406). This frequency is about 148991 times the estimated maximal expected allele frequency of a pathogenic ALK variant (0.0000004), suggesting this is likely a common benign polymorphism found primarily in the populations of African origin. The variant of interest has not, to our knowledge, been reported in affected individuals via publications. Taken together, this variant is classified as Benign.
GeneDx RCV000612129 SCV000731054 benign not specified 2017-02-21 criteria provided, single submitter clinical testing This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.